Spectrum Wealth Advisory Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Spectrum Wealth Advisory Group’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-11,023	Closed	-$17K	–	38
2022 Q3	$17K	Sell	11,023 -570	-5%	-$1.29K	0.02%	37
2022 Q2	$23K	Sell	11,593 -500	-4%	-$865	0.03%	43
2022 Q1	$28K	Sell	12,093 -1,500	-11%	-$4.68K	0.03%	46
2021 Q4	$63K	Sell	13,593 -4,500	-25%	-$27.9K	0.06%	49
2021 Q3	$138K	Hold	18,093	–	–	0.14%	42
2021 Q2	$175K	Sell	18,093 -1,000	-5%	-$7.96K	0.17%	44
2021 Q1	$158K	Sell	19,093 -3	-0%	-$32	0.15%	39
2020 Q4	$130K	Sell	19,096 -17,596	-48%	-$141K	0.15%	35
2020 Q3	$422K	Buy	36,692 +18,096	+97%	+$166K	0.27%	33
2020 Q2	$117K	Buy	+18,596	New	+$71.2K	0.17%	33

Other funds holding SRNE

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BRF

B. Riley Financial Los Angeles, California $434M AUM 751.56% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Spectrum Wealth Advisory Group's SRNE Position: Q4 2022 in Review

Spectrum Wealth Advisory Group sold out of Sorrento Therapeutics, Inc. (SRNE) in Q4 2022, closing a stake of 11,023 shares — an estimated $17K sold.

Spectrum Wealth Advisory Group first reported a position in SRNE in Q2 2020 and held it in 10 quarters. The position peaked at $422K in Q3 2020. 221 funds tracked by Wall St. Rank hold SRNE as of Q4 2022.

Spectrum Wealth Advisory Group reported no remaining Sorrento Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Spectrum Wealth Advisory Group sold 11,023 Sorrento Therapeutics, Inc. shares in Q4 2022, an estimated $17K.
Spectrum Wealth Advisory Group first reported a position in Sorrento Therapeutics, Inc. in Q2 2020 and held it in 10 quarters.
Spectrum Wealth Advisory Group's Sorrento Therapeutics, Inc. position peaked at $422K in Q3 2020.
221 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q4 2022.

Based on Spectrum Wealth Advisory Group's 13F filing for Q4 2022, filed 25 Jan 2023.